Works matching AU Celli, Monica

Results: 20

Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens.

Published in:

Hematological Oncology, 2013, v. 31, n. 4, p. 183, doi. 10.1002/hon.2039

By:

Zinzani, Pier Luigi;
Pellegrini, Cinzia;
Gandolfi, Letizia;
Casadei, Beatrice;
Derenzini, Enrico;
Broccoli, Alessandro;
Quirini, Federica;
Argnani, Lisa;
Pileri, Stefano;
Celli, Monica;
Fanti, Stefano;
Poletti, Venerino;
Stefoni, Vittorio;
Baccarani, Michele

Publication type:

Article

Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.

Published in:

2014

By:

Broccoli, Alessandro;
Pellegrini, Cinzia;
Celli, Monica;
Argnani, Lisa;
Agostinelli, Claudio;
Pileri, Stefano;
Zinzani, Pier Luigi

Publication type:

Journal Article

Consistency of FDG-PET Accuracy and Cost-Effectiveness in Initial Staging of Patients With Hodgkin Lymphoma Across Jurisdictions.

Published in:

Clinical Lymphoma, Myeloma & Leukemia, 2011, v. 11, n. 4, p. 314, doi. 10.1016/j.clml.2011.06.006

By:

Cerci, Juliano J.;
Trindade, Evelinda;
Buccheri, Valeria;
Fanti, Stefano;
Coutinho, Artur M. N.;
Zanoni, Lucia;
Linardi, Camila C. G.;
Celli, Monica;
Delbeke, Dominique;
Pracchia, Luís F.;
Pitela, Felipe A.;
Soares Jr, José;
Zinzani, Pier Luigi;
Meneghetti, José C.

Publication type:

Article

Correlation of [68Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2024, v. 52, n. 1, p. 326, doi. 10.1007/s00259-024-06887-4

By:

Giunta, Emilio Francesco;
Caroli, Paola;
Scarpi, Emanuela;
Altavilla, Amelia;
Rossetti, Virginia;
Marini, Irene;
Celli, Monica;
Casadei, Chiara;
Lolli, Cristian;
Schepisi, Giuseppe;
Bleve, Sara;
Brighi, Nicole;
Cursano, Maria Concetta;
Paganelli, Giovanni;
Matteucci, Federica;
De Giorgi, Ugo

Publication type:

Article

Combined Visual and Semi-quantitative Evaluation Improves Outcome Prediction by Early Mid-treatment 18F-fluoro-deoxi-glucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma.

Published in:

Journal of Nuclear Medicine, 2019, v. 60, n. 12, p. 1, doi. 10.2967/jnumed.119.23162

By:

Györke, Tamás;
Carr, Robert;
Cerci, Juliano J.;
Meneghetti, Claudio;
Redondo, Francisca;
Celli, Monica;
Gorospe, Charity;
Auewarakul, Chirayu U.;
Jorgov, Linda;
Paez, Diana;
Fanti, Stefano

Publication type:

Article

Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma.

Published in:

Journal of Nuclear Medicine, 2014, v. 55, n. 12, p. 1936, doi. 10.2967/jnumed.114.145326

By:

Carr, Robert;
Fanti, Stefano;
Paez, Diana;
Cerci, Juliano;
Györke, Tamás;
Redondo, Francisca;
Morris, Tim P.;
Meneghetti, Claudio;
Auewarakul, Chirayu;
Nair, Reena;
Gorospe, Charity;
Chung, June-Key;
Kuzu, Isinsu;
Celli, Monica;
Gujral, Sumeet;
Padua, Rose Ann;
Dondi, Maurizio

Publication type:

Article

Combined PET and Biopsy Evidence of Marrow Involvement Improves Prognostic Prediction in Diffuse Large B-Cell Lymphoma.

Published in:

Journal of Nuclear Medicine, 2014, v. 55, n. 10, p. 1591, doi. 10.2967/jnumed.113.134486

By:

Cerci, Juliano J.;
Györke, Tamás;
Fanti, Stefano;
Paez, Diana;
Meneghetti, José Cláudio;
Redondo, Francisca;
Celli, Monica;
Auewarakul, Chirayu;
Rangarajan, Venkatesh;
Gujral, Sumeet;
Gorospe, Charity;
Campo, Maejoy V.;
Chung, June-Key;
Morris, Tim P.;
Dondi, Maurizio;
Carr, Robert

Publication type:

Article

Early Biochemical Relapse After Radical Prostatectomy: Which Prostate Cancer Patients May Benefit from a Restaging 11C-Choline PET/CT Scan Before Salvage Radiation Therapy?

Published in:

Journal of Nuclear Medicine, 2014, v. 55, n. 9, p. 1424, doi. 10.2967/jnumed.114.138313

By:

Castellucci, Paolo;
Ceci, Francesco;
Graziani, Tiziano;
Schiavina, Riccardo;
Brunocilla, Eugenio;
Mazzarotto, Renzo;
Pettinato, Cinzia;
Celli, Monica;
Lodi, Filippo;
Fanti, Stefano

Publication type:

Article

Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2020, v. 47, n. 13, p. 3008, doi. 10.1007/s00259-020-04856-1

By:

Paganelli, Giovanni;
Sarnelli, Anna;
Severi, Stefano;
Sansovini, Maddalena;
Belli, Maria Luisa;
Monti, Manuela;
Foca, Flavia;
Celli, Monica;
Nicolini, Silvia;
Tardelli, Elisa;
Marini, Irene;
Matteucci, Federica;
Giganti, Melchiore;
Di Iorio, Valentina;
De Giorgi, Ugo

Publication type:

Article

68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 12, p. 2035, doi. 10.1007/s00259-018-4067-3

By:

Caroli, Paola;
Sandler, Israel;
Matteucci, Federica;
De Giorgi, Ugo;
Uccelli, Licia;
Celli, Monica;
Foca, Flavia;
Barone, Domenico;
Romeo, Antonino;
Sarnelli, Anna;
Paganelli, Giovanni

Publication type:

Article

Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2018, v. 45, n. 3, p. 348, doi. 10.1007/s00259-017-3866-2

By:

Caroli, Paola;
De Giorgi, Ugo;
Scarpi, Emanuela;
Fantini, Lorenzo;
Moretti, Andrea;
Galassi, Riccardo;
Celli, Monica;
Conteduca, Vincenza;
Rossi, Lorena;
Bianchi, Emanuela;
Paganelli, Giovanni;
Matteucci, Federica

Publication type:

Article

Reduction of Ga-PSMA renal uptake with mannitol infusion: preliminary results.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2017, v. 44, n. 13, p. 2189, doi. 10.1007/s00259-017-3791-4

By:

Matteucci, Federica;
Mezzenga, Emilio;
Caroli, Paola;
Iorio, Valentina;
Sarnelli, Anna;
Celli, Monica;
Fantini, Lorenzo;
Moretti, Andrea;
Galassi, Riccardo;
Giorgi, Ugo;
Paganelli, Giovanni

Publication type:

Article

Androgen deprivation therapy influences the uptake of C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study.

Published in:

European Journal of Nuclear Medicine & Molecular Imaging, 2011, v. 38, n. 11, p. 1985, doi. 10.1007/s00259-011-1867-0

By:

Fuccio, Chiara;
Schiavina, Riccardo;
Castellucci, Paolo;
Rubello, Domenico;
Martorana, Giuseppe;
Celli, Monica;
Malizia, Claudio;
Profitos, Marta;
Marzola, Maria;
Pettinato, Vincenzina;
Fanti, Stefano

Publication type:

Article

68 Ga-PSMA-11 PET/CT-Guided Stereotactic Body Radiation Therapy Retreatment in Prostate Cancer Patients with PSA Failure after Salvage Radiotherapy.

Published in:

Biomedicines, 2020, v. 8, n. 12, p. 536, doi. 10.3390/biomedicines8120536

By:

Caroli, Paola;
Colangione, Sarah Pia;
De Giorgi, Ugo;
Ghigi, Giulia;
Celli, Monica;
Scarpi, Emanuela;
Monti, Manuela;
Di Iorio, Valentina;
Sarnelli, Anna;
Paganelli, Giovanni;
Matteucci, Federica;
Romeo, Antonino

Publication type:

Article

Spotlight on PSMA as a new theranostic biomarker for bladder cancer.

Published in:

Scientific Reports, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41598-021-89160-0

By:

Tumedei, Maria Maddalena;
Ravaioli, Sara;
Matteucci, Federica;
Celli, Monica;
De Giorgi, Ugo;
Gunelli, Roberta;
Puccetti, Maurizio;
Paganelli, Giovanni;
Bravaccini, Sara

Publication type:

Article

Radiomics Analysis on [ 68 Ga]Ga-PSMA-11 PET and MRI-ADC for the Prediction of Prostate Cancer ISUP Grades: Preliminary Results of the BIOPSTAGE Trial.

Published in:

Cancers, 2022, v. 14, n. 8, p. 1888, doi. 10.3390/cancers14081888

By:

Feliciani, Giacomo;
Celli, Monica;
Ferroni, Fabio;
Menghi, Enrico;
Azzali, Irene;
Caroli, Paola;
Matteucci, Federica;
Barone, Domenico;
Paganelli, Giovanni;
Sarnelli, Anna

Publication type:

Article

Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol.

Published in:

Molecules, 2019, v. 24, n. 3, p. 621, doi. 10.3390/molecules24030621

By:

Sarnelli, Anna;
Belli, Maria Luisa;
Di Iorio, Valentina;
Mezzenga, Emilio;
Celli, Monica;
Severi, Stefano;
Tardelli, Elisa;
Nicolini, Silvia;
Oboldi, Devil;
Uccelli, Licia;
Cittanti, Corrado;
Monti, Manuela;
Ferrari, Mahila;
Paganelli, Giovanni

Publication type:

Article

Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin.

Published in:

British Journal of Haematology, 2013, v. 163, n. 5, p. 681, doi. 10.1111/bjh.12548

By:

Zinzani, Pier Luigi;
Derenzini, Enrico;
Pellegrini, Cinzia;
Celli, Monica;
Broccoli, Alessandro;
Argnani, Lisa

Publication type:

Article

Circulating androgen receptor gene amplification and resistance to 177Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial.

Published in:

2021

By:

De Giorgi, Ugo;
Sansovini, Maddalena;
Severi, Stefano;
Nicolini, Silvia;
Monti, Manuela;
Gurioli, Giorgia;
Foca, Flavia;
Casadei, Chiara;
Conteduca, Vincenza;
Celli, Monica;
Di Iorio, Valentina;
Calistri, Daniele;
Matteucci, Federica;
von Eyben, Finn Edler;
Attard, Gerhardt;
Paganelli, Giovanni

Publication type:

journal article

Diagnostic and Prognostic Potential of 18F-FET PET in the Differential Diagnosis of Glioma Recurrence and Treatment-Induced Changes After Chemoradiation Therapy.

Published in:

Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.721821

By:

Celli, Monica;
Caroli, Paola;
Amadori, Elena;
Arpa, Donatella;
Gurrieri, Lorena;
Ghigi, Giulia;
Cenni, Patrizia;
Paganelli, Giovanni;
Matteucci, Federica

Publication type:

Article

Works matching AU Celli, Monica

Extranodal marginal zone B-cell lymphoma of the lung: experience with fludarabine and mitoxantrone-containing regimens.

Single-agent lenalidomide is effective in the treatment of a heavily pretreated and refractory angioimmunoblastic T-cell lymphoma patient.

Consistency of FDG-PET Accuracy and Cost-Effectiveness in Initial Staging of Patients With Hodgkin Lymphoma Across Jurisdictions.

Correlation of [<sup>68</sup>Ga]Ga-PSMA PET/CT response and PSA decline in first-line enzalutamide for metastatic castration-resistant prostate cancer patients.

Combined Visual and Semi-quantitative Evaluation Improves Outcome Prediction by Early Mid-treatment <sup>18</sup>F-fluoro-deoxi-glucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma.

Prospective International Cohort Study Demonstrates Inability of Interim PET to Predict Treatment Failure in Diffuse Large B-Cell Lymphoma.

Combined PET and Biopsy Evidence of Marrow Involvement Improves Prognostic Prediction in Diffuse Large B-Cell Lymphoma.

Early Biochemical Relapse After Radical Prostatectomy: Which Prostate Cancer Patients May Benefit from a Restaging <sup>11</sup>C-Choline PET/CT Scan Before Salvage Radiation Therapy?

Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients.

<sup>68</sup>Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients.

Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.

Reduction of Ga-PSMA renal uptake with mannitol infusion: preliminary results.

Androgen deprivation therapy influences the uptake of C-choline in patients with recurrent prostate cancer: the preliminary results of a sequential PET/CT study.

68 Ga-PSMA-11 PET/CT-Guided Stereotactic Body Radiation Therapy Retreatment in Prostate Cancer Patients with PSA Failure after Salvage Radiotherapy.

Spotlight on PSMA as a new theranostic biomarker for bladder cancer.

Radiomics Analysis on [ 68 Ga]Ga-PSMA-11 PET and MRI-ADC for the Prediction of Prostate Cancer ISUP Grades: Preliminary Results of the BIOPSTAGE Trial.

Dosimetry of 177Lu-PSMA-617 after Mannitol Infusion and Glutamate Tablet Administration: Preliminary Results of EUDRACT/RSO 2016-002732-32 IRST Protocol.

Bendamustine efficacy in Hodgkin lymphoma patients relapsed/refractory to brentuximab vedotin.

Circulating androgen receptor gene amplification and resistance to <sup>177</sup>Lu-PSMA-617 in metastatic castration-resistant prostate cancer: results of a Phase 2 trial.

Diagnostic and Prognostic Potential of <sup>18</sup>F-FET PET in the Differential Diagnosis of Glioma Recurrence and Treatment-Induced Changes After Chemoradiation Therapy.